It was time to hold a court and the subject for discussion was the future of that prisoner.

A federal appeals court overturned the prior decision, ruling that Myriad Genetics could indeed hold patents to two genes that help forecast a woman's risk of breast cancer.

For reasons that remain unclear, the case was heard by a military court, where the judge tried to hold the trial in private, claiming that the jury was afraid of being seen on television.